208 related articles for article (PubMed ID: 395094)
1. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
Kerner W; Beischer W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
[TBL] [Abstract][Full Text] [Related]
2. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
Christiansen JS; Svendsen PA; Deckert T
Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
[TBL] [Abstract][Full Text] [Related]
3. Control algorithms for artificial beta cell.
Clemens AH
Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
[TBL] [Abstract][Full Text] [Related]
4. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas.
Drouin P; Rousselle D; Pointel JP; Voisin G; Stoltz JF; Clemens AH; Debry G
Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064
[TBL] [Abstract][Full Text] [Related]
5. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell.
Kerner W; Thum C; Tamás G; Beischer W; Clemens AH; Pfeiffer EF
Horm Metab Res; 1976 Jul; 8(4):256-61. PubMed ID: 783030
[TBL] [Abstract][Full Text] [Related]
6. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
Froesch ER; Blatter G; Morell B
Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
[TBL] [Abstract][Full Text] [Related]
7. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
8. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
[TBL] [Abstract][Full Text] [Related]
9. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
10. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
Beyer J; Wolf E; Cordes U; Hassingen W
Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
[TBL] [Abstract][Full Text] [Related]
11. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
Stavljenić A; Granić M; Topić B; Skrabalo Z
Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
[TBL] [Abstract][Full Text] [Related]
13. Metabolic studies during normoglycaemic clamping of insulin-dependent diabetics using a glucose-controlled insulin infusion system.
Nattrass M; Alberti KG; Buckle AL; Cluett B; Jaspan JB; Noy GA; Stubbs WA; Walton R
Horm Metab Res Suppl; 1979; (8):86-92. PubMed ID: 395096
[TBL] [Abstract][Full Text] [Related]
14. Use of an artificial beta cell in surgery.
Horwitz DL; Schwartz SS
Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
[TBL] [Abstract][Full Text] [Related]
15. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
[No Abstract] [Full Text] [Related]
16. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
[TBL] [Abstract][Full Text] [Related]
17. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
[TBL] [Abstract][Full Text] [Related]
19. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
Lambert AE; Buysschaert M; Lambotte L
Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
[No Abstract] [Full Text] [Related]
20. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
Mirouze J; Selam JL; Pham TC; Orsetti A
Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]